| Takeda Pharma AG - Intuniv 4 mg, Retardtabletten | | 66130 | | 04 | | Intuniv 4 mg | | Retardtabletten | | C02AC02 | | Guanfacine | | 15.09.2017 | | |
| | Composition | | guanfacinum 4 mg ut guanfacini hydrochloridum 4.56 mg, hypromellosum, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, natrii laurilsulfas corresp. natrium 0.054581 mg, polysorbatum 80, cellulosum microcristallinum, silica colloidalis anhydrica, lactosum monohydricum 53.07 mg, povidonum K 30, crospovidonum, glyceroli dibehenas, acidum fumaricum, E 132, E 172 (flavum), pro compresso. | | Packungsbestandteile | | Delayed release tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 4 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | | | | | | | Hypromellosum | | | | Lactose Monohydrate | 53.07 mg | | | | | | | Polysorbatum 80 | | | | | 30 | | | | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
